In a recent Phase III Type I diabetes trial, IQVIA faced aggressive timelines to meet a submission deadline. IQVIA accelerated site identification and patient recruitment to help our customer meet the critical regulatory filing dates.

Learn More

IQVIA Core-Powered Clinical Development. Our CORE-powered approach to clinical development dramatically increases speed and efficiency to help you bring your products to patients faster. • Accelerate site identification by up to 40%. • Increase patient enrollment by up to 30%. • Applied to more than 200 clinical studies.

Proof, not promises.

Learn More

Data based on a recent Phase III Type I diabetes trial. Comparisons based on previous studies in the same indication and geographies conducted by IQVIA. Results may vary due to various factors.